Full-Time

Sales & Account Manager

Guardian Pharmacy Services

Guardian Pharmacy Services

1,001-5,000 employees

Decentralized LTC pharmacy with national support

No salary listed

Gainesville, VA, USA

In Person

Travel of approximately 75–80% is required; occasional evenings, weekends, and overnight travel may be required.

Bachelor's

Category
Sales & Account Management (1)
Required Skills
Sales
CRM
Word/Pages/Docs
Salesforce
Marketing
Excel/Numbers/Sheets

Get referred to Guardian Pharmacy Services

See people who can refer or advise you

Requirements
  • A bachelor's degree is preferred.
  • A valid driver's license and clean driving record are required.
  • At least 2 years of new sales or account management experience in long-term care, assisted living, skilled nursing, geriatric facilities, pharmaceutical, or pharmacy settings is required; an advanced degree may substitute for experience.
  • Advanced computer skills and pharmacy operations system experience are preferred/required.
  • A proven track record of sales success is required.
  • Existing relationships with long-term care Directors of Nursing or administrators are a plus.
  • Proficiency in Microsoft Word, Excel, and PowerPoint is required.
  • Daily Salesforce.com updates are required.
  • Accuracy in weekly activity reports is required.
  • Strong selling skills and professional value-added selling skills are required.
  • The ability to customize the sales approach based on a potential client's response is required.
  • The ability to work independently, meet objectives and targets with little supervision, and deliver to deadlines is required.
  • The ability to solve problems with minimal direction and maintain attention to detail and accuracy is required.
  • A valid driver's license is required for travel of approximately 75–80%.
  • Occasional evening, weekend, or overnight work may be required, and a flexible schedule is required.
Responsibilities
  • Drive growth and expand the company's footprint in the long-term care market.
  • Proactively identify and close new business opportunities within assigned territories.
  • Nurture existing relationships and develop new business with nursing homes, assisted living facilities, and other long-term care facilities.
  • Market the local business as a preferred provider to facility residents and families at monthly family nights.
  • Ensure sales agreements with new clients meet business-unit profitability targets.
  • Maintain client contracts and relationships through expert-advisor status and problem-solving.
  • Act as liaison with operations to maintain a high service level and follow service-related issues through resolution.
  • Provide consulting services to client facilities to assist with compliance.
  • Provide in-service training to client staff as needed.
  • Participate in local association meetings related to assisted living and long-term care facilities.
  • Participate in designing collateral for the target client group, with the goal of designing independently.
  • Maintain visibility through membership and participation in national-level industry associations.
  • Help manage contracts and ensure pharmacy solutions are effectively positioned to increase revenue.
  • Assist in achieving the budget through sales to new clients and increased sales to existing clients.
  • Participate in developing marketing materials, including collateral and electronic materials, to support sales projects.
  • Present the Guardian Pharmacy identity at targeted local and national trade and industry events while maintaining sensitivity to local brand identity.
  • Evaluate the potential profitability of new business before proposal in collaboration with Pharmacy Operations and Finance & Administration directors.
  • Build positive working relationships with clients by resolving issues, advising on regulatory matters, and training client staff as needed.
Desired Qualifications
  • Pharmacy or pharmaceutical industry experience is preferred.
  • Pharmacy operations system experience is preferred.
  • Positive existing relationships with long-term care Directors of Nursing or administrators are a plus.
Guardian Pharmacy Services

Guardian Pharmacy Services

View

Guardian Pharmacy Services runs a network of long-term care pharmacies in the United States using a local-autonomy model, where each pharmacy operates as a local business with some owner-ship by local managers while a national team provides centralized support. It dispenses medications and offers medication management, 24/7 access, advanced packaging, and clinical support from pharmacists who specialize in geriatric and complex care, backed by GuardianShield data analytics to aid facility decisions. The company serves residents in assisted living, memory care, skilled nursing, hospice, and related settings across 38 states, with a national footprint of over 53 pharmacies serving more than 204,000 residents. Its goal is to improve medication safety and adherence while reducing overall healthcare costs through tailored, community-focused care and scalable corporate resources.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Atlanta, Georgia

Founded

2004

Get referred to Guardian Pharmacy Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 2.2%, and residents reached 210,000.
  • August 6, 2026 guidance increased again after Wellness Concepts and Lexington launches.
  • Acquisitions and greenfields keep expanding Guardian’s footprint without sacrificing local leadership continuity.

What critics are saying

  • July 2026 IRA pricing cuts crushed organic revenue, masking underlying demand strength.
  • About 71% of 2025 revenue came from Medicare Part D, concentrating reimbursement exposure.
  • If drug pricing reforms deepen in 2027, Guardian’s growth model loses economic engine.

What makes Guardian Pharmacy Services unique

  • Decentralized local-ownership pharmacies, plus centralized support, drive faster market-specific execution.
  • GuardianShield and Guardian Compass turn LTC data into contracting and clinical advantage.
  • By August 2026, Guardian scaled to 61 pharmacies across 38 states.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Life Insurance

Disability Insurance

401(k) Company Match

Paid Holidays

Paid Sick Leave

Paid Vacation

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

15%

1 year growth

15%

2 year growth

15%
Yahoo Finance
Aug 13th, 2026
Guardian Pharmacy Services grows revenue 2% in Q2 2026 despite IRA pricing impact

Guardian Pharmacy Services reported second quarter 2026 results, with revenue growing 2% through the first half of the year. Chief Executive Officer Fred Burke noted the company would have seen low double-digit revenue growth excluding IRA pricing reductions, which he described as a clearer indication of underlying business growth. The company attributed its performance to solid fundamentals across local markets and progress on strategic priorities, including geographic expansion. Burke emphasised that Guardian continues to execute well despite pricing pressures. The results covered the quarter ended 30 June 2026. Company executives, including Burke, Chief Operating Officer David Morris, and Chief Financial Officer Will Mudd, discussed the performance during an earnings call.

Business Wire
Jul 2nd, 2026
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts

Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia.

Yahoo Finance
May 10th, 2026
Guardian Pharmacy navigates IRA pricing changes with 19% gross profit growth in Q1

Guardian Pharmacy Services reported first-quarter 2026 revenue of $336.6 million, up 2% year over year, despite significant pricing pressure from the Inflation Reduction Act's new framework. CEO Fred Burke said the company experienced approximately 60% price declines on IRA-selected drugs, noting that revenue would have grown by low double digits without these government-mandated reductions. The company reported gross profit of $76 million, up 19% year over year, with adjusted EBITDA rising 27% to $29.8 million. Total residents increased 10% to approximately 207,000, with script volumes also up 10%. CFO David Morris attributed growth to organic expansion, acquisitions and plan optimisation efforts. Guardian raised its adjusted EBITDA guidance whilst maintaining its full-year revenue outlook following the quarter.

Yahoo Finance
May 8th, 2026
Guardian Pharmacy offsets 60% IRA-driven branded drug pricing decline with 2% Q1 revenue growth

Guardian Pharmacy Services reported 2% revenue growth in Q1 2026, offsetting a 60% decline in branded drug pricing from the Inflation Reduction Act through renegotiated payer contracts. The company updated full-year adjusted EBITDA guidance to $123 million–$127 million, reflecting a $3 million discrete first-quarter benefit. Underlying fundamentals remained strong, with 10% year-over-year growth in resident count and prescription volumes. However, operational complexity increased due to Medicare's new Transaction Facilitator platform, causing working capital timing shifts expected to normalise throughout the year. Results included $3.2 million in legal expenses for reimbursement advocacy, with an $8.5 million settlement to be recognised in Q2. Recent acquisitions dampened margins by 80 basis points. Management expects labour costs to rise modestly as the company invests in regional leadership whilst maintaining its acquisition pace.

Bitget
Mar 18th, 2026
Guardian's $21 synthetic secondary suggests undervaluation as 35% discount reflects earnings momentum

Guardian Pharmacy Services has priced a follow-on offering at $21 per share, raising approximately $181 million in a synthetic secondary. The offering price represents a 35% discount to the previous closing price of $32.59, though the stock had already declined 2.60% over the past month. The company reported strong 2025 results, with revenue of $1.45 billion (up 18%) and adjusted EBITDA of $115.1 million (up 53%). Management raised 2026 EBITDA guidance to $120–$124 million, but revenue projections remain flat at $1.40–$1.42 billion, signalling a growth slowdown. Guardian's shares trade at a trailing P/E of 55.19, with a market capitalisation near $2.20 billion. Analysts rate the stock a moderate buy with a price target around $32, indicating limited upside as the market has absorbed recent earnings surprises.